Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy

Abstract

IMPORTANCE Solid estimates of the risk of developing symptoms and of progressing to critical disease in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are key to interpreting coronavirus disease 2019 (COVID-19) dynamics, identifying the settings and the segments of the population where transmission is more likely to remain undetected, and defining effective control strategies. OBJECTIVE To estimate the association of age with the likelihood of developing symptoms and the association of age with the likelihood of progressing to critical illness after SARS-CoV-2 infection. DESIGN, SETTING, AND PARTICIPANTS This cohort study analyzed quarantined case contacts, identified between February 20 and April 16, 2020, in the Lombardy region of Italy. Contacts were monitored daily for symptoms and tested for SARS-CoV-2 infection, by either real-time reverse transcriptase-polymerase chain reaction using nasopharyngeal swabs or retrospectively via IgG serological assays. Close contacts of individuals with laboratory-confirmed COVID-19 were selected as those belonging to clusters (ie, groups of contacts associated with an index case) where all individuals were followed up for symptoms and tested for SARS-CoV-2 infection. Data were analyzed from February to June 2020. EXPOSURE Close contact with individuals with confirmed COVID-19 cases as identified by contact tracing operations. MAIN OUTCOMES AND MEASURES Age-specific estimates of the risk of developing respiratory symptoms or fever greater than or equal to 37.5°C and of experiencing critical disease (defined as requiring intensive care or resulting in death) in SARS-CoV-2-infected case contacts. RESULTS In total, 5484 case contacts (median [interquartile range] age, 50 [30-61] years; 3086 female contacts [56.3%]) were analyzed, 2824 of whom (51.5%) tested positive for SARS-CoV-2 (median [interquartile range] age, 53 [34-64] years; 1604 female contacts [56.8%]). The proportion of infected persons who developed symptoms ranged from 18.1% (95% CI, 13.9%-22.9%) among participants younger than 20 years to 64.6% (95% CI, 56.6%-72.0%) for those aged 80 years or older. Most infected contacts (1948 of 2824 individuals [69.0%]) did not develop respiratory symptoms or fever greater than or equal to 37.5°C. Only 26.1% (95% CI, 24.1%-28.2%) of infected individuals younger than 60 years developed respiratory symptoms or fever greater than or equal to 37.5°C; among infected participants older than 60 years, 6.6% (95% CI, 5.1%-8.3%) developed critical disease. Female patients were 52.7% (95% CI, 24.4%-70.7%) less likely than male patients to develop critical disease after SARS-CoV-2 infection. (continued) Key Points Question What is the association of age Open Access. This is an open access article distributed under the terms of the CC-BY License.

COVID-19 mitigation by digital contact tracing and contact prevention (app-based social exposure warnings)

“…This distribution depends on agent age and coincides with the function that describes IDR2 in Fig. 1 (estimated from Polettis results 20 ). As observed in the graph, the probability of symptomatic infection increases with age.…”

Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021

“…14 . Further, we overlay a disease burden model on the transmission model to estimate the number of symptomatic cases, hospitalizations, intensive care unit (ICU) admissions and deaths under different vaccination scenarios and based on empirical data [15][16][17][18][19][20] . The resulting integrated model is informed by data on COVID-19 natural history, age-mixing patterns specific to China quantified during the pre-pandemic period and the size of the different vaccination targets in the Chinese population (for example, individuals with pre-existing conditions).…”

Feasibility and efficacy of mass testing for SARS-CoV-2 in a UK university using swab pooling and PCR

“…Multiple outbreaks of COVID-19 have occurred in higher education institutions, often associated with large social gatherings and student accommodation, in spite of infection control measures introduced to prevent viral transmission [22][23][24] . Amongst university students (typically, healthy young adults), the rate of asymptomatic infection is expected to be higher than in the general population 25,26 . In principle, mass testing is therefore particularly suited to preventing transmission between university students.…”